Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.
Bombardier Inc. (BBD.B-T) says its transportation divison has received an order from Lower Saxony’s regional public transport operator in Germany, Landesnahverkehrsgesellschaft Niedersachsen (LNVG), for 14 additional Bombardier Twindexx Vario double-deck coaches.
“A total of 12 intermediate cars and two control cars will be delivered,” the company stated, increasing LNVG’s fleet to 246 Twindexx Vario double-deck coaches in addition to the 37 Traxx locomotives already in service.
**
Neptune Wellness Solutions, Inc. (NEPT-Q; NEPT-T) announced an import and stocking distribution partnership with “one of the world’s leading consumer goods companies.”
Neptune said it expects to receive first shipments of products into its inventory by the end of October. “It should be noted that the distribution agreement does not require any minimum annual purchase commitments, acceptance of orders placed by Neptune are at the discretion of the global consumer product company. Accordingly, there is no certainty at this time that the full deal size will be realized,” the company stated.
**
Dye & Durham Ltd. (DND-T) says it lost $3.8-million in its fourth quarter compared with a profit of $1.7-million in the same quarter a year earlier.
The cloud-based software company says the loss amounted to 18 cents per diluted share for the three months ended June 30 compared with a profit of eight cents per share a year earlier.
Revenue slipped to $14.2-million compared with $15.1-million a year ago.
The result came as Dye & Durham says it cut $4.1-million in costs compared with its third quarter through permanent and temporary measures in response to the COVID-19 pandemic.
Dye & Durham completed its initial public offering and began trading on the Toronto Stock Exchange on July 17.
It raised $172.5-million in the offering and over-allotment option.
-The Canadian Press
**
Knight Therapeutics Inc. (GUD-T) and TherapeuticsMD, Inc. (TXMD-Q) announced the approval of Bijuva capsules by Health Canada.
Bijuva helps with menopause symptoms, such as hot flashes and night sweats, the company said.
Knight signed a license agreement with TherapeuticsMD in July 2018 for the exclusive Canadian commercialization rights to Bujuva. The agreement sees Knight pay TherapeuticsMD a milestone fee for the regulatory approval in Canada of Bijuva, as well as sales milestone fees and royalties.
**
Fiera Capital Corp. (FSZ-T) announced the appointment of Anik Lanthier as president of its public markets division, effective Oct. 13.
“Anik will be responsible for all of Fiera Capital’s public markets activities globally which group the firm’s equity, fixed income, liquid alternatives and multi-asset class solutions offering,” the company stated.
Her most recent role was as senior vice-president and global head of capital markets at PSP Investments.
**
Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.